Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q4 2019 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2020-02-13

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 13, 2020

Total Value: $143M (100.0% shares, 0.0% debt)

Holdings (23)

— AMARIN CORP PLC -ADR 23.2%

Value $33.26M Shares 1,551,300 Share Price $21.44 Est. Cost/Share $9.14 Unrealized @ Report Date —

— IVERIC BIO INC 17.9%

Value $25.74M Shares 3,000,000 Share Price $8.58 Est. Cost/Share $1.30 Unrealized @ Report Date —

— AFFIMED NV 7.7%

Value $10.99M Shares 4,010,155 Share Price $2.74 Est. Cost/Share $2.75 Unrealized @ Report Date —

— OXFORD IMMUNOTEC GLOBAL PLC 7.3%

Value $10.47M Shares 630,862 Share Price $16.60 Est. Cost/Share $16.13 Unrealized @ Report Date —

— ADAMAS PHARMACEUTICALS INC 5.9%

Value $8.494M Shares 2,241,239 Share Price $3.79 Est. Cost/Share $4.81 Unrealized @ Report Date —

— NEOS THERAPEUTICS INC 5.1%

Value $7.337M Shares 4,858,889 Share Price $1.51 Est. Cost/Share $1.80 Unrealized @ Report Date —

— CTI BIOPHARMA CORP 4.1%

Value $5.933M Shares 3,755,000 Share Price $1.58 Est. Cost/Share $3.05 Unrealized @ Report Date —

XOMA XOMA CORP 3.8%

Value $5.478M Shares 200,667 Share Price $27.30 * Est. Cost/Share $13.89 Unrealized @ Report Date +61.1%

— OPIANT PHARMACEUTICALS INC 3.4%

Value $4.814M Shares 334,272 Share Price $14.40 Est. Cost/Share $15.93 Unrealized @ Report Date —

EOLS EVOLUS INC 3.4%

Value $4.806M Shares 394,890 Share Price $12.17 * Est. Cost/Share $14.10 Unrealized @ Report Date 0.0%

— APOLLO ENDOSURGERY INC 3.3%

Value $4.706M Shares 1,651,333 Share Price $2.85 Est. Cost/Share $4.40 Unrealized @ Report Date —

CPIX CUMBERLAND PHARMACEUTICALS 3.2%

Value $4.615M Shares 896,170 Share Price $5.15 * Est. Cost/Share $5.82 Unrealized @ Report Date -9.2%

— HTG MOLECULAR DIAGNOSTICS 2.3%

Value $3.34M Shares 4,758,426 Share Price $0.70 Est. Cost/Share $1.63 Unrealized @ Report Date —

— AEGERION PHARMACEUTICALS INC 2.0%

Value $2.844M Shares 2,993,334 Share Price $0.95 Est. Cost/Share $0.95 Unrealized @ Report Date —

— NOVELION THERAPEUTICS INC 1.9%

Value $2.759M Shares 3,909,207 Share Price $0.71 Est. Cost/Share $0.73 Unrealized @ Report Date —

— APTEVO THERAPEUTICS INC 1.9%

Value $2.735M Shares 4,179,131 Share Price $0.65 Est. Cost/Share $0.86 Unrealized @ Report Date —

— CATALYST BIOSCIENCES INC 1.5%

Value $2.093M Shares 307,287 Share Price $6.81 Est. Cost/Share $6.81 Unrealized @ Report Date —

— CHIASMA INC 0.6%

Value $911K Shares 183,660 Share Price $4.96 Est. Cost/Share $4.95 Unrealized @ Report Date —

— STRONGBRIDGE BIOPHARMA PLC 0.6%

Value $903K Shares 431,853 Share Price $2.09 Est. Cost/Share $2.09 Unrealized @ Report Date —

— SCYNEXIS INC 0.4%

Value $555K Shares 609,384 Share Price $0.91 Est. Cost/Share $0.91 Unrealized @ Report Date —

IDXG INTERPACE BIOSCIENCES INC 0.3%

Value $472K Shares 943,851 Share Price $0.50 Est. Cost/Share $0.50 Unrealized @ Report Date —

— RESTORBIO INC 0.1%

Value $122K Shares 81,772 Share Price $1.49 Est. Cost/Share $1.49 Unrealized @ Report Date —

— ACER THERAPEUTICS INC 0.1%

Value $80,000 Shares 20,000 Share Price $4.00 Est. Cost/Share $3.19 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	AMARIN CORP PLC -ADR	1,551,300	$33.26M	23.2%	$21.44	$9.14	—	SPONS ADR NEW	023111206
—	IVERIC BIO INC	3,000,000	$25.74M	17.9%	$8.58	$1.30	—	COM	46583P102
—	AFFIMED NV	4,010,155	$10.99M	7.7%	$2.74	$2.75	—	COM	N01045108
—	OXFORD IMMUNOTEC GLOBAL PLC	630,862	$10.47M	7.3%	$16.60	$16.13	—	ORD SHS	G6855A103
—	ADAMAS PHARMACEUTICALS INC	2,241,239	$8.494M	5.9%	$3.79	$4.81	—	COM	00548A106
—	NEOS THERAPEUTICS INC	4,858,889	$7.337M	5.1%	$1.51	$1.80	—	COM NEW	64052L106
—	CTI BIOPHARMA CORP	3,755,000	$5.933M	4.1%	$1.58	$3.05	—	COM	12648L601
XOMA	XOMA CORP	200,667	$5.478M	3.8%	$27.30 *	$13.89	+61.1%	COM NEW	98419J206
—	OPIANT PHARMACEUTICALS INC	334,272	$4.814M	3.4%	$14.40	$15.93	—	COM	683750103
EOLS	EVOLUS INC	394,890	$4.806M	3.4%	$12.17 *	$14.10	0.0%	COM	30052C107
—	APOLLO ENDOSURGERY INC	1,651,333	$4.706M	3.3%	$2.85	$4.40	—	COM	03767D108
CPIX	CUMBERLAND PHARMACEUTICALS	896,170	$4.615M	3.2%	$5.15 *	$5.82	-9.2%	COM	230770109
—	HTG MOLECULAR DIAGNOSTICS	4,758,426	$3.34M	2.3%	$0.70	$1.63	—	COM	40434H104
—	AEGERION PHARMACEUTICALS INC	2,993,334	$2.844M	2.0%	$0.95	$0.95	—	NOTE 5.000% 4/0	00767EAC6
—	NOVELION THERAPEUTICS INC	3,909,207	$2.759M	1.9%	$0.71	$0.73	—	COM	67001K202
—	APTEVO THERAPEUTICS INC	4,179,131	$2.735M	1.9%	$0.65	$0.86	—	COM	03835L108
—	CATALYST BIOSCIENCES INC	307,287	$2.093M	1.5%	$6.81	$6.81	—	COM NEW	14888D208
—	CHIASMA INC	183,660	$911K	0.6%	$4.96	$4.95	—	COM	16706W102
—	STRONGBRIDGE BIOPHARMA PLC	431,853	$903K	0.6%	$2.09	$2.09	—	SHS USD	G85347105
—	SCYNEXIS INC	609,384	$555K	0.4%	$0.91	$0.91	—	COM	811292101
IDXG	INTERPACE BIOSCIENCES INC	943,851	$472K	0.3%	$0.50	$0.50	—	COM NEW	46062X303
—	RESTORBIO INC	81,772	$122K	0.1%	$1.49	$1.49	—	COM	76133L103
—	ACER THERAPEUTICS INC	20,000	$80,000	0.1%	$4.00	$3.19	—	COM	00444P108